NFG
PETX

Next Financial Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Next Financial Group’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-350
Closed -$3K – 2532
2016
Q3 		$3K Hold
350
– – ﹤0.01% 2114
2016
Q2 		$2K Buy
350
+50
+17% +$322 ﹤0.01% 1623
2016
Q1 		$1K Sell
300
-2,100
-88% -$7.9K ﹤0.01% 1691
2015
Q4 		$13K Buy
2,400
+600
+33% +$3.96K ﹤0.01% 1101
2015
Q3 		$15K Buy
1,800
+100
+6% +$1.69K 0.01% 1063
2015
Q2 		$25K Buy
+1,700
New +$24.5K 0.01% 922

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Next Financial Group's PETX Position: Q4 2016 in Review

Next Financial Group sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2016, closing a stake of 350 shares — an estimated $3K sold.

Next Financial Group first reported a position in PETX in Q2 2015 and held it in 6 quarters. The position peaked at $25K in Q2 2015. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • Next Financial Group reported no remaining Aratana Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Next Financial Group sold 350 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $3K.
  • Next Financial Group first reported a position in Aratana Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
  • Next Financial Group's Aratana Therapeutics, Inc. position peaked at $25K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on Next Financial Group's 13F filing for Q4 2016, filed 2 Feb 2017.